Brisa Fernandes

Summary

Publications

  1. doi request reprint Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
    Brisa S Fernandes
    Deakin University, IMPACT Strategic Research Centre, School of Medicine, Geelong, Australia
    BMC Med 13:289. 2015
  2. doi request reprint Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis
    Brisa Simões Fernandes
    Bipolar Disorder Program, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
    J Psychiatr Res 45:995-1004. 2011
  3. pmc Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial
    Michael Berk
    Deakin University, School of Medicine, Barwon Health, P O Box 291, Geelong, 3220, Australia
    BMC Med 10:91. 2012
  4. doi request reprint Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients
    Brisa Fernandes
    Bipolar Disorder Program, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
    Neurosci Lett 453:195-8. 2009

Detail Information

Publications4

  1. doi request reprint Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
    Brisa S Fernandes
    Deakin University, IMPACT Strategic Research Centre, School of Medicine, Geelong, Australia
    BMC Med 13:289. 2015
    ..Therefore, it is now possible to analyse the association between BDNF levels and the severity of affective symptoms in BD as well as the effects of acute drug treatment of mood episodes on BDNF levels...
  2. doi request reprint Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis
    Brisa Simões Fernandes
    Bipolar Disorder Program, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
    J Psychiatr Res 45:995-1004. 2011
    ..In euthymia, BDNF decreases with age and length of illness. These data suggest that peripheral BDNF could be used as a biomarker of mood states and disease progression for BD...
  3. pmc Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial
    Michael Berk
    Deakin University, School of Medicine, Barwon Health, P O Box 291, Geelong, 3220, Australia
    BMC Med 10:91. 2012
    ..The current study aimed to investigate the maintenance effects of NAC following eight weeks of open-label treatment for bipolar disorder...
  4. doi request reprint Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients
    Brisa Fernandes
    Bipolar Disorder Program, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
    Neurosci Lett 453:195-8. 2009
    ..001). There were no changes in the serum BDNF before and after the ECT treatment (p=0.89). These results do not support the hypothesis that the clinical improvement following ECT is due to changes in the BDNF...